Diabetic Innovations: New Insulin Inhaler - Afrezza

Mike CastagnaCEO of MannKind, joins Dame and Raquel in the kitchen to talk about Afrezza - the only FDA approved inhaled insulin. Dame has been an Afrezza user for less than a year and has already dropped to his goal A1C of 7, yet wonders why more people aren’t aware of this life-changing drug. Mike shares the challenges he faces working with the healthcare industry that’s stuck in the past.

Watch why you should fight for your health on this week’s episode of DDN.